Leap Therapeutics, Inc.
USD0.77
-0.03 (-3.15%)
CEO
Douglas E. Onsi
IPO Date
2017-01-25
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.76
Prev. Close
$0.79
Day Low
$0.74
Day High
$0.80
52W Low
$0.22
52W High
$3.58
Market Cap
$0.03B
Volume
0.85M
| -1.6 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -135.4% | -111.8% | 0.00 | 5.64 | -1.0 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -99.9% | -94.0% | 0.01 | 17.07 | -0.9 |
| 31 Dec 2021 | FY | 100.0% | -2705.8% | -37.6% | -34.4% | 0.00 | 11.70 | -6.9 |
| 31 Dec 2020 | FY | 50.9% | -33.7% | -5.0% | -4.8% | 0.01 | 37.37 | -39.4 |
| 31 Dec 2019 | FY | 52.9% | -35.6% | -60.2% | -39.6% | 0.18 | 3.50 | -7.3 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -252.2% | -121.3% | 0.00 | 2.69 | -1.2 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -267.4% | -102.3% | 0.00 | 4.55 | -1.9 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | 25.6% | -397.0% | -0.30 | 0.11 | -2.9 |
| 0.5 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -1.4% | -1.1% | 0.01 | 8.66 | -1.4 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -291.1% | -83.0% | 0.01 | 1.34 | -0.2 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -74.1% | -44.3% | 0.01 | 2.41 | -0.2 |
| 31 Dec 2024 | Q4 | -4461.5% | -17166.2% | -114.6% | -81.8% | 0.01 | 3.41 | -0.7 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -37.1% | -27.9% | 0.01 | 3.97 | -1.5 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -5.9% | -5.2% | 0.01 | 27.73 | -0.9 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -6.0% | -5.0% | 0.01 | 12.98 | -1.3 |
| 31 Dec 2023 | Q4 | -1713.6% | -7322.0% | -41.0% | -33.9% | 0.00 | 5.64 | -1.1 |